amyloid β drug
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| amyloid β | biomarker_for | Alzheimer's disease | — | 1 |
| amyloid β | interacts_with | Cd14 | — | 1 |
| amyloid β | risk_factor_for | neuroinflammation | — | 1 |
| amyloid β | interacts_with | Tlr2 | — | 1 |
| amyloid β | interacts_with | Tlr4 | — | 1 |
| APP | regulates | amyloid β | — | 1 |
Mentioned in (4)
Papers in which this entity is mentioned.
- Interpretation of risk loci from genome-wide association studies of Alzheimer's disease. (2020)
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes. (2016)
- Oxidative stress signaling to chromatin in health and disease. (2016)
- Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. (2014)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| amyloid β | drug | 4 | 4 |